Is bone transplantation the gold standard for repair of alveolar bone defects?

Journal of Tissue Engineering

Volumn 5, Issue , 2014, Pages

  Raposo Amaral, Cassio Eduardo ^a   Bueno, Daniela Franco ^a   Almeida, Ana Beatriz ^a   Jorgetti, Vanda ^a   Costa, Cristiane Cabral ^a   Gouveia, Cecília Helena ^a   Vulcano, Luiz Carlos ^b   Fanganiello, Roberto D ^a   Passos Bueno, Maria Rita ^a   Alonso, Nivaldo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

alveolar defect; biomaterial; bone; bone tissue engineering; osseous defect; Stem cell; tricalcium phosphate

Indexed keywords

BIOMATERIALS; CELL CULTURE; CELL ENGINEERING; COMPUTERIZED TOMOGRAPHY; DEFECTS; MAMMALS; MINERALS; STEM CELLS; TISSUE ENGINEERING;

ALVEOLAR DEFECT; BONE DEFECT; BONE MINERALS; BONE TISSUE ENGINEERING; BOVINE BONE; MESENCHYMAL STEM CELL; OSSEOUS DEFECTS; STEM-CELL; TRI-CALCIUM PHOSPHATES; Α-TRICALCIUM PHOSPHATE;

BONE;

CALCIUM PHOSPHATE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEFECT; BONE GRAFT; BONE REMODELING; BONE TRANSPLANTATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; IMMUNOPHENOTYPING; MALE; MESENCHYMAL STEM CELL; MORPHOMETRICS; NONHUMAN; ORBICULARIS ORIS MUSCLE; PRIORITY JOURNAL; RAT; TISSUE ENGINEERING;

EID: 84938583095     PISSN: None     EISSN: 20417314     Source Type: Journal    
DOI: 10.1177/2041731413519352     Document Type: Article

References (44)

1. U.KneserD.J.SchaeferE.Polykandriotis. Tissue engineering of bone: the reconstructive surgeon’s point of view. J Cell Mol Med2006; 10: 7–19.
2. Z.H.BaqainM.AnabtawiA.A.Karaky. Morbidity from anterior iliac crest bone harvesting for secondary alveolar bone grafting: an outcome assessment study. J Oral Maxillofac Surg2009; 67: 570–575.
3. S.GoudyD.LottR.Burton. Secondary alveolar bone grafting: outcomes, revisions, and new applications. Cleft Palate Craniofac J2009; 46: 610–612.
4. R.LangerJ.P.Vacanti. Tissue engineering. Science1993; 260: 920–926.
5. C.SzpalskiM.WetterauJ.Barr. Bone tissue engineering: current strategies and techniques—part I: scaffolds. Tissue Eng Part B Rev2012; 18: 246–257.
6. C.SzpalskiM.BarbaroF.Sagebin. Bone tissue engineering: current strategies and techniques—part II: cell types. Tissue Eng Part B Rev2012; 18: 258–269.
7. C.A.VacantiJ.P.Vacanti. The science of tissue engineering. Orthop Clin North Am2000; 31: 351–356.
8. J.P.Vacanti. Editorial: tissue engineering: a 20-year personal perspective. Tissue Eng2007; 13: 231–232.
9. J.P.VacantiR.Langer. Tissue engineering: the design and fabrication of living replacement devices for surgical reconstruction and transplantation. Lancet1999; 354: SI32–SI34.
10. M.C.NolffN.C.GellrichG.Hauschild. Comparison of two beta-tricalcium phosphate composite grafts used for reconstruction of mandibular critical size bone defects. Vet Comp Orthop Traumatol2009; 22: 96–102.
11. J.G.PintoB.T.PrimoH.T.Gassen. Alpha-tricalcium phosphate cement in the reconstruction of bone defects in rats. Acta Cir Bras2011; 26: 135–139.
12. H.RojbaniM.NyanK.Ohya. Evaluation of the osteoconductivity of alpha-tricalcium phosphate, beta-tricalcium phosphate, and hydroxyapatite combined with or without simvastatin in rat calvarial defect. J Biomed Mater Res A2011; 98: 488–498.
13. M.KamitakaharaC.OhtsukiT.Miyazaki. Review paper: behavior of ceramic biomaterials derived from tricalcium phosphate in physiological condition. J Biomater Appl2008; 23: 197–212.
14. N.MokbelC.Bou SerhalG.Matni. Healing patterns of critical size bony defects in rat following bone graft. Oral Maxillofac Surg2008; 12: 73–78.
15. M.PayerB.LohbergerE.Stadelmeyer. Behaviour of multipotent maxillary bone-derived cells on beta-tricalcium phosphate and highly porous bovine bone mineral. Clin Oral Implants Res2010; 21: 699–708.
16. Z.SchwartzT.WeesnerS.van Dijk. Ability of deproteinized cancellous bovine bone to induce new bone formation. J Periodontol2000; 71: 1258–1269.
17. F.I.TapetyN.AmizukaK.Uoshima. A histological evaluation of the involvement of Bio-Oss in osteoblastic differentiation and matrix synthesis. Clin Oral Implants Res2004; 15: 315–324.
18. M.DominiciK.Le BlancI.Mueller. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy2006; 8: 315–317.
19. E.M.HorwitzK.Le BlancM.Dominici. Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement. Cytotherapy2005; 7: 393–395.
20. D.F.BuenoI.KerkisA.M.Costa. New source of muscle-derived stem cells with potential for alveolar bone reconstruction in cleft lip and/or palate patients. Tissue Eng Part A2009; 15: 427–435.
21. T.Takano-YamamotoM.KawakamiM.Sakuda. Defects of the rat premaxilla as a model of alveolar clefts for testing bone-inductive agents. J Oral Maxillofac Surg1993; 51: 887–891.
22. C.E.Raposo-AmaralG.S.KobayashiA.B.Almeida. Alveolar osseous defect in rat for cell therapy: preliminary report. Acta Cir Bras2010; 25: 313–317.
23. J.B.MullikenJ.Glowacki. Induced osteogenesis for repair and construction in the craniofacial region. Plast Reconstr Surg1980; 65: 553–560.
24. T.L.ArinzehS.J.PeterM.P.Archambault. Allogeneic mesenchymal stem cells regenerate bone in a critical-sized canine segmental defect. J Bone Joint Surg Am2003; 85-A: 1927–1935.
25. D.D.CarradeV.K.AffolterC.A.Outerbridge. Intradermal injections of equine allogeneic umbilical cord-derived mesenchymal stem cells are well tolerated and do not elicit immediate or delayed hypersensitivity reactions. Cytotherapy2011; 13: 1180–1192.
26. C.K.ChuangK.J.LinC.Y.Lin. Xenotransplantation of human mesenchymal stem cells into immunocompetent rats for calvarial bone repair. Tissue Eng Part A2010; 16: 479–488.
27. A.De Mendonca CostaD.F.BuenoM.T.Martins. Reconstruction of large cranial defects in nonimmunosuppressed experimental design with human dental pulp stem cells. J Craniofac Surg2008; 19: 204–210.
28. T.FatkhudinovD.V.GoldshteinA.A.Pulin. Reparative osteogenesis during transplantation of mesenchymal stem cells. Bull Exp Biol Med2005; 140: 96–99.
29. T.JazedjeD.F.BuenoB.V.Almada. Human fallopian tube mesenchymal stromal cells enhance bone regeneration in a xenotransplanted model. Stem Cell Rev2012; 8: 355–362.
30. A.M.ParfittM.K.DreznerF.H.Glorieux. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res1987; 2: 595–610.
31. O.O.AalamiR.P.NacamuliK.A.Lenton. Applications of a mouse model of calvarial healing: differences in regenerative abilities of juveniles and adults. Plast Reconstr Surg2004; 114: 713–720.
32. J.W.Frame. A convenient animal model for testing bone substitute materials. J Oral Surg1980; 38: 176–180.
33. J.O.HollingerJ.C.Kleinschmidt. The critical size defect as an experimental model to test bone repair materials. J Craniofac Surg1990; 1: 60–68.
34. A.De RuiterG.MeijerT.Dormaar. Beta-TCP versus autologous bone for repair of alveolar clefts in a goat model. Cleft Palate Craniofac J2011; 48: 654–662.
35. H.YuanJ.D.De BruijnY.Li. Bone formation induced by calcium phosphate ceramics in soft tissue of dogs: a comparative study between porous alpha-TCP and beta-TCP. J Mater Sci Mater Med2001; 12: 7–13.
36. P.D.NguyenC.D.LinA.C.Allori. Establishment of a critical-sized alveolar defect in the rat: a model for human gingivoperiosteoplasty. Plast Reconstr Surg2009; 123: 817–825.
37. C.M.SchmittH.DoeringT.Schmidt. Histological results after maxillary sinus augmentation with Straumann(R) BoneCeramic, Bio-Oss(R), Puros(R), and autologous bone. A randomized controlled clinical trial. Clin Oral Implants Res2013; 24: 576–585.
38. H.J.ChoiJ.M.KimE.Kwon. Establishment of efficacy and safety assessment of human adipose tissue-derived mesenchymal stem cells (hATMSCs) in a nude rat femoral segmental defect model. J Korean Med Sci2011; 26: 482–491.
39. M.JafarianM.B.EslaminejadA.Khojasteh. Marrow-derived mesenchymal stem cells-directed bone regeneration in the dog mandible: a comparison between biphasic calcium phosphate and natural bone mineral. Oral Surg Oral Med Oral Pathol Oral Radiol Endod2008; 105: e14–e24.
40. P.J.TaubJ.YauM.Spangler. Bioengineering of calvaria with adult stem cells. Plast Reconstr Surg2009; 123: 1178–1185.
41. J.A.ConejeroJ.A.LeeB.M.Parrett. Repair of palatal bone defects using osteogenically differentiated fat-derived stem cells. Plast Reconstr Surg2006; 117: 857–863.
42. J.Y.LeeD.MusgraveD.Pelinkovic. Effect of bone morphogenetic protein-2-expressing muscle-derived cells on healing of critical-sized bone defects in mice. J Bone Joint Surg Am2001; 83-A: 1032–1039.
43. Z.QuL.GuoG.Fang. Biological characteristics and effect of human umbilical cord mesenchymal stem cells (hUC-MSCs) grafting with blood plasma on bone regeneration in rats. Cell Biochem Biophys2012; 63: 171–181.
44. M.Di NicolaC.Carlo-StellaM.Magni. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood2002; 99: 3838–3843.